MedTrace Logo

MatrixRIB Implants for Surgical Stabilization of Flail Chest Injuries: A Registry

NCT00810251 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2011-07-06

No results posted yet for this study

Summary

The purpose of this observational study is to document the treatment of serial rib fractures with MatrixRIB implants in a registry.

Conditions

  • Flail Chest

Interventions

DEVICE

MatrixRIB (FDA Approval # K081623)

MatrixRIB implants are comprised of anatomic rib plates and intramedullary rib splints for internal surgical stabilization of rib fractures.

Sponsors & Collaborators

  • Synthes Inc.

    collaborator INDUSTRY

  • Legacy Biomechanics Laboratory

    lead OTHER

Principal Investigators

  • Michael Bottlang, PhD · Legacy Clinical Research & Technology Center

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2011-04-30
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00810251 on ClinicalTrials.gov